Literature DB >> 15684736

Diversity and relatedness among the type I interferons.

Jiabing Chen1, Ehtesham Baig, Eleanor N Fish.   

Abstract

Type I interferons (IFNs) include the IFN-alpha family of subtypes, IFN-beta, IFN-omega, IFN-tau, IFN-kappa, IFN-lambda, and IFN-zeta. IFN genes lack introns and encode secretory signal peptide sequences that are proteolytically cleaved prior to secretion from the cell. In contrast to the approximately 50% amino acid sequence identity among the human IFN-alpha subtypes, human IFN-alphas share approximately 22% identity with human IFN-beta and 37% identity with human IFN-omega. Many of the conserved residues among the type I IFNs are implicated in receptor recognition and structural integrity. This report provides an update on the gene annotations for the mouse and human IFN gene clusters on chromosome 4 and 9, respectively, with accompanying amino acid sequence alignments. Based on sequence identities, a phylogenic tree analysis for the different mammalian Type I IFNs is also presented, showing the high degree of relatedness among these IFNs. Notably, sequence alignment of the different human and mouse IFN promoter regions reveals different signature patterns for transcription factor binding sites, implying different inducers might differentially activate the transcription of the different IFNs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15684736     DOI: 10.1089/jir.2004.24.687

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  27 in total

1.  Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.

Authors:  Luiz F Leomil Coelho; Gabriel Magno de Freitas Almeida; Franck J D Mennechet; Anne Blangy; Gilles Uzé
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

2.  Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice.

Authors:  Carsten Kallfass; Andreas Ackerman; Stefan Lienenklaus; Siegfried Weiss; Bernd Heimrich; Peter Staeheli
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

3.  Interferon type I receptor-deficient mice have altered disease symptoms in response to influenza virus.

Authors:  Tim R Traynor; Jeannine A Majde; Stewart G Bohnet; James M Krueger
Journal:  Brain Behav Immun       Date:  2006-11-13       Impact factor: 7.217

4.  Protein phosphatase 1 abrogates IRF7-mediated type I IFN response in antiviral immunity.

Authors:  Ling Wang; Juan Zhao; Junping Ren; Kenton H Hall; Jonathan P Moorman; Zhi Q Yao; Shunbin Ning
Journal:  Eur J Immunol       Date:  2016-08-29       Impact factor: 5.532

5.  Genomic analysis and mRNA expression of equine type I interferon genes.

Authors:  Olivier Detournay; David A Morrison; Bettina Wagner; Behdad Zarnegar; Eva Wattrang
Journal:  J Interferon Cytokine Res       Date:  2013-06-17       Impact factor: 2.607

Review 6.  Interferons, signal transduction pathways, and the central nervous system.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

Review 7.  Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections.

Authors:  Staci Kearney; Christine Delgado; Laurel L Lenz
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

8.  Differential regulation of human interferon A gene expression by interferon regulatory factors 3 and 7.

Authors:  Pierre Génin; Rongtuan Lin; John Hiscott; Ahmet Civas
Journal:  Mol Cell Biol       Date:  2009-04-06       Impact factor: 4.272

9.  Long-term pegylated interferon-alpha and its potential in the treatment of melanoma.

Authors:  Reinhard Dummer; Joanna Mangana
Journal:  Biologics       Date:  2009-07-13

10.  Stabilization of human interferon-α1 mRNA by its antisense RNA.

Authors:  Tominori Kimura; Shiwen Jiang; Mikio Nishizawa; Emi Yoshigai; Iwao Hashimoto; Masao Nishikawa; Tadayoshi Okumura; Hisao Yamada
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.